Researchers at Queen's University Belfast and the University College London have reportedly found a drug normally used to treat cardiovascular disease may also help combat diabetic retinopathy.
Through research in partnership with GlaxoSmithKline, researchers found the drug Darapladib inhibits an enzyme called Lp-PLA2, which is normally increased in those with diabetes. According to scientists, Lp-PlA2 causes blood vessel leakage in the eye, which leads to retina swelling and severe vision loss.
The researchers are reportedly planning a clinical trial of their findings. Their current research was published in the scientific journal Proceeding of the National Academy of Science USA (PNAS).
Click here to read the full press release.
Source: Queen's University Belfast